[Advances of Targeting Therapy in Acute Myeloid Leukemia--Review].

Tian, Chen; Li, Yue-Yang; Hu, Dong-Zhi

Tian, Chen; Li, Yue-Yang; Hu, Dong-Zhi.

Afiliação

Tian C; Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China E-mail: tcgirl2001@sina.com.
Li YY; Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
Hu DZ; Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.

Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 26(4): 1253-1256, 2018 Aug.

Article em Zh | MEDLINE | ID: mdl-30111441

Assuntos

Leucemia Mieloide Aguda; Protocolos de Quimioterapia Combinada Antineoplásica; Citarabina; Humanos; Mutação; Prognóstico; Recidiva

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Tipo de estudo: Prognostic_studies Limite: Humans Idioma: Zh Revista: Zhongguo Shi Yan Xue Ye Xue Za Zhi Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google